Table 2.

Statements without overall consensus.

Statements that reached consensus	Level of agreement (%)
	Total	Pn	Rh	Ra
Q1: What are the main risk factors for the development of ILD in ARDs?
1.5—The severity of skin involvement in case of systemic sclerosis correlates with an increased risk of ILD.	51	26	79	44
1.7—The risk of developing ILD tends to increase with the age of onset of ARD, such as in the case of rheumatoid arthritis.	73	65	79	78
Q3: What are the rheumatological signs and symptoms that pulmonologists need to evaluate in generating a suspicion of ARD in patients with ILD?
3.6—Presence of joint deformations can raise the suspicion of ARD in a patient with ILD.	71	76	61	82
3.8—Presence of alteration in phlogosis indexes can generate suspicion of ARD in a patient with ILD.	35	31	30	53
3.9—Morning functional impotence can raise suspicion of ARD in a patient with ILD.	53	55	49	59
3.10—Presence of subcutaneous nodules may raise suspicion of ARD in a patient with ILD.	66	62	58	88
3.11—Presence of a feeling of hyposthenia can generate suspicion of ARD in an ILD patient.	44	41	46	47
Q4: What should be the monitoring timing and frequency of pulmonary symptoms in the patient with ARD?
4.2—Pulmonary symptoms in ARD patients should be monitored every 12 months for stable rheumatic disease or low-risk patients.	70	66	67	82
4.8—In the case of high-risk patients (i.e., diffuse systemic sclerosis with the presence of anti-scl70 antibodies) pulmonary symptoms should be evaluated every 3 months while high-resolution chest CT should be performed every 12 months.	72	76	67	77
Q6: What can be ways to implement multidisciplinary management of ARD patients with suspicion of ILD?
6.6—Creation of “smart” digital platforms for each MDT group can facilitate multidisciplinary management of rheumatology patients with suspicion of ILD.	72	68	64	94

Pn, pneumologists; Rh, rheumatologists; Ra, radiologists; Values in bold highlight a reached consensus within a specialty.